Abcam adds director
Debt Ceiling Debate: IR Teams Should Prepare for Potential Market Downturns
Insight Weekly: Loan-to-deposit ratio rises; inventory turnovers ebb; miners add female leaders
Insight Weekly: Sustainable bonds face hurdles; bad loans among landlords; AI investments up
Insight Weekly: Bank oversight steps up; auto insurers’ dismal year; VC investment slumps
Abcam Plc appointed Giles Kerr to the board as a nonexecutive director, effective Dec. 12.
Kerris is a nonexecutive director at Arix Bioscience PLC, Isis Innovation Ltd. and Oxford Sciences Innovation.
Cambridge, U.K.-based Abcam produces and distributes research-grade antibodies and associated protein research tools worldwide.
